Idea AG
Munich, DE· latest recorded location
IDEA AG is named on 5 US grants and 12 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 5
- Published applications
- 12
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 22 Sep 2009
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 3 |
| 2009 | 2 | 4 |
By publication year.
Technology areas
Share of 17 documents
Recent patents
- Method for the improvement of transport across adaptable semi-permeable barriers22 Sep 2009US 7,591,949 B2
- NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery6 Jan 2009US 7,473,432 B2
- Method for the improvement of transport across adaptable semi-permeable barriers2 Dec 2008US 7,459,171 B2
- Formulation for topical non-invasive application in vivo13 Feb 2007US 7,175,850 B2
- Preparation for the application of agents in mini-droplets26 Dec 2000US 6,165,500 A
- Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin18 Jun 2009US 2009/0155235 A1
- Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery5 Mar 2009US 2009/0060989 A1
- Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery5 Mar 2009US 2009/0060990 A1
- Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery12 Feb 2009US 2009/0042989 A1
- Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates18 Dec 2008US 2008/0311184 A1
Most cited
By later US patents
- Preparation for the application of agents in mini-droplets185US 6,165,500 A2000
- NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery77US 7,473,432 B22009
- Formulation for topical non-invasive application in vivo75US 7,175,850 B22007
- Method for the improvement of transport across adaptable semi-permeable barriers6US 7,459,171 B22008
- Method for the improvement of transport across adaptable semi-permeable barriers6US 7,591,949 B22009